首页> 美国卫生研究院文献>other >Personal genome testing on physicians improves attitudes on pharmacogenomic approaches
【2h】

Personal genome testing on physicians improves attitudes on pharmacogenomic approaches

机译:对医生的个人基因组测试改善了对药物基因组学方法的态度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this era of clinical genomics, the accumulation of knowledge of pharmacogenomics (PGx) is rising dramatically and attempts to utilize it in clinical practice are also increasing. However, this advanced knowledge and information have not yet been sufficiently utilized in the clinical field due to various barriers including physician factors. This study was conducted to evaluate the attitudes of physicians to PGx services by providing them their own genomic data analysis report focusing on PGx. We also tried to evaluate the clinical applicability of whole exome sequencing (WES)-based functional PGx test. In total 88 physicians participated in the study from September 2015 to August 2016. Physicians who agreed to participate in the study were asked to complete a pre-test survey evaluating their knowledge of and attitude toward clinical genomics including PGx. Only those who completed the pre-test survey proceeded to WES and were provided with a personal PGx analysis report in an offline group meeting. Physicians who received these PGx reports were asked to complete a follow-up survey within two weeks. We then analyzed changes in their knowledge and attitude after reviewing their own PGx analysis results through differences in their pre-test and post-test survey responses. In total, 70 physicians (79.5%) completed the pre-test and post-test surveys and attended an off-line seminar to review their personal PGx reports. After physicians reviewed the report, their perception of and attitude towards the PGx domain and genomics significantly changed. Physician’ awareness of the likelihood of occurrence of adverse drug reactions and genetic contribution was also changed significantly. Overall, physicians were very positive about the value and potential of the PGx test but maintained a conservative stance on its actual clinical use. Results revealed that physicians’ perception and attitude to the utility of PGx testing was significantly changed after reviewing their own WES results.
机译:在这个临床基因组学时代,药物基因组学(PGx)知识的积累急剧增加,并且在临床实践中利用它的尝试也在增加。但是,由于包括医生因素在内的各种障碍,这种先进的知识和信息尚未在临床领域中得到充分利用。通过向他们提供他们自己的针对PGx的基因组数据分析报告,本研究旨在评估医生对PGx服务的态度。我们还尝试评估基于全外显子组测序(WES)的功能性PGx测试的临床适用性。从2015年9月到2016年8月,共有88位医生参加了该研究。要求同意参加该研究的医师完成一项测试前调查,评估他们对包括PGx在内的临床基因组学的知识和态度。只有完成了测试前调查的人员才进入WES,并在离线小组会议中获得个人PGx分析报告。要求收到这些PGx报告的医师在两周内完成随访调查。然后,在通过测试前和测试后调查回应中的差异审查了自己的PGx分析结果之后,我们分析了他们的知识和态度变化。总共有70位医生(79.5%)完成了测试前和测试后的调查,并参加了离线研讨会,以复查他们的个人PGx报告。在医师审查了该报告后,他们对PGx域和基因组学的认识和态度发生了重大变化。医生对药物不良反应和遗传贡献发生可能性的认识也发生了很大变化。总体而言,医生对PGx测试的价值和潜力非常乐观,但对实际临床使用仍持保守立场。结果显示,医生对自己的WES结果进行审查后,对PGx测试效用的看法和态度发生了显着变化。

著录项

  • 期刊名称 other
  • 作者单位
  • 年(卷),期 -1(14),3
  • 年度 -1
  • 页码 e0213860
  • 总页数 18
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号